Study to Improve Detection and Early Recurrence Rate in Bladder Cancer Patients Using Hexvix Fluorescence Cystoscopy
Recruiting in Palo Alto (17 mi)
+24 other locations
Overseen ByH Barton Grossman
Age: 18+
Sex: Any
Travel: May be covered
Time Reimbursement: Varies
Trial Phase: Phase 3
Waitlist Available
Sponsor: Photocure
No Placebo Group
Pivotal Trial (Near Approval)
Prior Safety Data
Trial Summary
What is the purpose of this trial?The purpose of this study is to document the additional detection of papillary bladder cancer and the reduced early recurrence due to the improved detection and resection of these tumors after Hexvix cystoscopy compared to standard cystoscopy in patients with papillary bladder cancer.
Eligibility Criteria
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Standard White Light and Hexvix Fluorescence CystoscopyExperimental Treatment2 Interventions
Group II: Standard White Light CystoscopyActive Control1 Intervention
Find A Clinic Near You
Research locations nearbySelect from list below to view details:
The Emory Clinic, Dept of UrologyAtlanta, GA
Hackensack University Medical CenterHackensack, NJ
St. Joseph Mercy Hospital- Ann ArborAnn Arbor, MI
V.A. Medical CenterGainesville, FL
More Trial Locations
Loading ...
Who is running the clinical trial?
PhotocureLead Sponsor